CRISPR基因编辑技术在上皮性卵巢癌研究中产生的模型的研究进展
本文综述了上皮性卵巢癌(EOC)分子机制与治疗策略的研究进展,以及CRISPR基因组编辑技术及其产生的EOC模型,讨论了CRISPR在构建EOC小鼠模型中的优势与障碍,以及通过体内递送基因编辑组件矫正EOC癌基因的有前景的治疗方法。
要点
- EOC是最致命的妇科癌症,常在晚期才被诊断。
- 小鼠模型在阐明卵巢癌发生分子机制及治疗策略中起关键作用。
- 更精确的动物模型及对EOC分子机制的深入理解将极大有益于EOC的研究与治疗。
核心结论
- 更精确的动物模型以及对EOC分子机制的更深入理解,将极大有益于EOC的研究与治疗。
研究设计与样本
- 本文为综述,概述了EOC发生的分子机制、治疗策略、CRISPR基因组编辑技术及其产生的EOC模型的研究进展,并综合讨论了CRISPR在生成EOC小鼠模型中的优势与障碍,以及通过体内递送基因编辑组件矫正EOC癌基因的有前景的治疗方法。
主要发现
- EOC是最致命的妇科癌症,常在晚期才被诊断,这促使探索新的治疗策略。
- 小鼠模型在阐明卵巢癌发生及其治疗策略的分子机制中发挥了关键作用。
- 在动物模型中模拟卵巢癌的遗传驱动因素仍存在各种挑战。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epithelial ovarian carcinoma (EOC), the most lethal gynecologic cancer, is often diagnosed at advanced stages, which urge us to explore the novel therapeutic strategies. Mouse models have played a crucial role in elucidating the molecular mechanisms for the development ovarian cancer and its therapeutic strategies. However, there are still various challenges in modeling the genetic drivers of ovarian cancer in animal models. Here, we provided an overview of the research advances for the molecular mechanisms underlying EOC development, therapeutic strategies, the CRISPR genome editing technology and its generated EOC models. The review also comprehensively discussed the advantages and obstacles of CRISPR in generating EOC mouse models and the promising therapeutic approach by correcting the oncogenes of EOC through in vivo delivery of gene-edited components. The development of more precise animal models, along with a deeper understanding of EOC molecular mechanisms, will dramatically benefit the investigation and treatment of EOC.
引用
- Li X, Wang Z, Man X, et al. Research advances CRISPR gene editing technology generated models in the study of epithelial ovarian carcinoma. Gynecol Oncol. 2025. PMID: 40054045. doi:10.1016/j.ygyno.2025.02.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。